Recurrent late-onset neutropenia after ofatumumab treatment in a case of multiple sclerosis
Abstract Objective Immunomodulatory treatment options for multiple sclerosis show an inverse risk‒benefit ratio of side effects and treatment efficacy. Although rare, anti-B-cell therapies can cause acute or late-onset neutropenia. Methods We report a case of severe recurrent fluctuating neutropenia...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Neurological Research and Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s42466-025-00377-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|